On September 24-25, 2009, the FDA is holding public workshop entitled “Providing Effective Information to Consumers About Prescription Drug Risks and Benefits.” Comments on workshop documents (including a series of prototypes on different written approaches to conveying prescription drug information to consumers) will be accepted until November 25, 2009.